|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7088 | (2006.01) |
| C12N2310/315 | (2013.01) | ||
| C12N 15/113 | (2010.01) | ||
| C12N2310/322 | (2013.01) | ||
| C12N2310/3341 | (2013.01) | ||
| C12N2310/341 | (2013.01) | ||
| C12N2310/346 | (2013.01) | ||
| C12N 15/113 | (2013.01) | ||
| A61K 31/7088 | (2013.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| C12N2310/14 | (2013.01) |
| (11) | Number of the document | 3400947 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18179911.5 |
| Date of filing the European patent application | 2014-02-14 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361764969 P | 2013-02-14 | US | |
| 201361880779 P | 2013-09-20 | US |
| (72) |
ALEXANDER, Veronica J. , US
VINEY, Nicholas J. , US
WITZTUM, Joseph L. , US
|
| (73) |
Ionis Pharmaceuticals, Inc. ,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS |
| MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS |